Fill-finish, release, and stability testing of HIV-1 GP120 proteins $2,302,002 on can 17-8470035.
Ended Awarded Last action
- Contract number
- HHSN27200002
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,017,609
Award facts
- Opportunity
-
- NIHAI2015035 Solicitation number
- Contract value 100% obligated
- $3,017,609.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $191,043 | |
| Change Order | $524,564 | |
| Original award | $2,302,002 |
About this award
This is a $3,017,609 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL) for fill-finish, release, and stability testing of HIV-1 gp120 proteins. The contract has an ultimate completion date of April 15, 2025. ABL is a for-profit organization that specializes in the development of biologics, vaccines, and immunotherapies. This contract is part of NIAID's preclinical development support program and does not have a set-aside designation. ABL has been awarded numerous federal contracts and grants, particularly from NIH and the Department of Health and Human Services, to advance the development of medical countermeasures for infectious diseases.
Quick answers
Who was awarded contract HHSN27200002?
HHSN27200002 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 20, 2017.
How much is contract HHSN27200002 worth?
The government has obligated $3,017,609 on HHSN27200002.
Is contract HHSN27200002 an order under another contract?
Yes. HHSN27200002 is a delivery order under HHSN272201700010I, an indefinite delivery contract.
Was contract HHSN27200002 competed?
The extent of competition for HHSN27200002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award